INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Dispelling Common Clinical Trial Oversight Myths
Many clinical trial oversight problems can be avoided or mitigated by sponsor understanding root causes and being a proactive collaborator with its partners.
-
Taming The Complex Clinical-Trial Ecosystem
To navigate the growing number of vendor portals required for clinical trials, sites are seeking a vendor- and sponsor-agnostic solution to enable single sign-on and study organization.
-
How Clinical Research Skyrocketed Revenue For A Private GI Practice
Uncover how this small gastrointestinal (GI) practice successfully integrated clinical research into its operations and made valuable contributions to the field.
-
From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined
Explore examples of smarter SAD/MAD trial designs including multi-part and hybrid protocols, regulatory foresight, recruitment considerations, and operational strategies that keep programs moving.
-
Flipping The Drug Development Industry On Its Head6/18/2024
The video dives into the obstacles of the traditional outsourcing relationship between CROs and sponsors, and how Altasciences has broken from tradition to offer an alternative model.
-
The Right CRO Is An Extension Of Your Brand: Here's Why It Matters9/23/2025
For sponsors eyeing Australia, CROs with deep local expertise unlock the region’s advantages and, coupled with a global outlook, can ensure your trial aligns with international regulatory expectations.
-
Rescuing A Global Program For NDA Success8/12/2025
Explore the collaboration that enabled FDA approval of a novel chronic-condition therapy, rescued a high-risk program, and demonstrated a unified “one-team” approach by reworking the sponsor's SAP.
-
Tailored Solutions For A Global Phase III Neovascular AMD Study3/17/2025
How did a Phase III combination study for neovascular age-related macular degeneration (AMD) overcome study complexities while expanding across 16 countries?
-
Why Functional Outsourcing Is Important To Clinical Development8/1/2025
Craig McIlloney, Senior Vice President of Catalyst Flex, discusses why functional outsourcing is important in today's clinical development environment, how Catalyst Flex supports this, and is scalable to flex to your changing needs.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.
-
Phase I clinical trials need technological solutions that support rapid implementation and end-to-end processes. Signant’s unified eClinical platform provides the perfect partner for Phase I research.
-
Explore data solutions for every clinical study - whether you are engaging our comprehensive CRO services or require specific, functional solutions to support your project.
-
Once material is packaged, secondary packaging is a crucial part of the preparation process. Ropack doesn’t leave anything to chance, with secondary contract packaging services to ensure your products are ready for market when you need them to be.
-
In the face of the COVID-19 pandemic, biopharmaceutical companies had to react quickly to develop and implement what were frequently large scale crisis response initiatives. Read how now is the time to assess the changes that were implemented and refine business continuity plans to ensure regulatory compliance, patient safety, and organizational preparedness now and into the future.